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INTRODUCTION
Primary breast sarcomas are rare, histologically heterogenous 
nonepithelial malignancies that arise from the connective tissue 
within the breast [1]. Like soft tissue sarcomas originating in 
other parts of the body, breast sarcomas consist of a heteroge-
neous group of several subtypes: liposarcoma, fibrosarcoma, 
pleomorphic sarcoma, leiomyosarcoma, rhabomyosarcoma, 
angiosarcoma, and osteosarcoma, sarcomas of uncertain dif-
ferentiation [2].
Undifferentiated pleomorphic sarcoma has been defined as 
a group of pleomorphic, high-grade sarcomas in which any 
attempt to disclose their line of differentiation has failed. It 
constitutes less than 5% of all sarcomas in adults [3] and has 
been rarely seen in breast [4]. The clinical features of this rare 
tumor mimic those of breast carcinoma and often presents   
diagnostic challenges [5].
Herein, we report a case of primary undifferentiated pleo-
morphic sarcoma in a 76-year-old man; this case highlights a 
rare and interesting variant of primary breast sarcoma and the 
diagnostic difficulty that physician and pathologist may encoun-
ter with it.
CASE REPORT
We report a case of spindle cell sarcoma of the breast in a 
76-year-old man. He presented to the Daegu Catholic Univer-
sity Hospital with a lump in his left breast that had been pres-
ent for the previous two months. He had been taking medica-
tion for hypertension and benign prostate hypertrophy and 
had not suffered trauma to his chest wall. Further, he had no 
family history of malignancy, including breast cancer.
On physical examination, the patient had a poorly demar-
cated, mobile, firm mass in his left breast. The mass was non-
tender, approximately 1 cm in diameter, and was detected in the 
subareolar area of the left breast. There was no clinical evidence 
of regional lymphadenopathy, and there were no abnormal 
findings in the right breast. Mammography revealed a dense 
lesion occupying the subareolar region; this lesion was consis-
tent with prominent fibroglandular tissue and suggested asym-
metric left gynecomastia (Figure 1A). Ultrasonography revealed 
a poorly demarcated and highly suspicious malignant lesion 
in the periareolar area of his left breast, and the lesion was cat-
egorized according to Breast Imaging Report and Data System 
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Undifferentiated pleomorphic sarcoma of the breast are uncom-
mon and often present diagnostic challenges. Herein, we report 
a case of the undifferentiated pleomorphic sarcoma occurring in 
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bean-sized mass in his left breast for two months. Core needle 
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sarcoma. Undifferentiated pleomorphic sarcoma of the breast 
can cause genuine diagnostic difficulty and appropriate immu-
nohistochemistry is mandatory for differential diagnosis.
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(BIRADS) as BIRADS 4C (Figure 1B). He underwent ultra-
sound-guided core needle biopsy, which indicated the presence 
of atypical cells in the fibrous, proliferative lesion (Figure 2). 
Preoperative examination consisted of a complete blood count, 
serum kidney and liver function test, thyroid function test, and 
tests for the levels of several hormones related to the develop-
ment of gynecomastia, including estrogen, testosterone, pro-
lactin, and gonadotrophic hormones. All results were within 
the normal limits.
The patient underwent wide excision of the lesion, including 
removal of normal breast tissue to provide a safety margin and 
he did not require subsequent axillary lymph node dissection. 
Gross examination of the specimen revealed a whitish, fibrotic 
nodular lesion, measuring 1.5×1 cm in size including surround-
ing adipose tissue. The specimen was fixed in 10% formalin. 
Paraffin sections were prepared and stained with haematoxy-
lin and eosin (H&E). Microscopic examination of the sections 
from the specimen showed nodular proliferation of fibrous 
tissue with focal infiltrating margins (Figure 3A). There were 
no ductal components and epithelial tissues. The nodules were 
composed of plump to spindle-shaped fibroblasts, many lym-
phoplasma cells, eosinophilic infiltrate, and many keloid-like 
collagen bundles (Figure 3B). A few atypical multinuclear giant 
cells and pleomorphic cells were noted; however, abnormal 
mitosis was not identified. Immunohistochemical staining for 
desmin, smooth muscle actin (SMA), and S-100 protein was 
negative (Figure 3C). These diverse histological and immuno-
histochemical findings established the diagnosis of atypical 
spindle cell lesion with uncertain malignant potential, exhibit-
ing features of a reactive fibroblastic lesion. 
The patient’s progress was monitored after the operation, 
and no specific adjuvant treatment was administered. One year 
later, he returned with a recurrent mass at the previous surgical 
site. On physical examination, a firm mass of about 2 cm in 
diameter was palpated in the wound from the previous surgery. 
Radiological studies, including computed tomography (CT) 
and positron emission tomography-CT (PET-CT), were con-
ducted, and PET-CT showed faint fluorodeoxyglucose uptake 
in the area of the left breast that corresponded to the lesion seen 
on the CT scan (Figure 4). There was no evidence of either   
regional lymphadenopathy or distant metastasis. The lesion 
was surgically removed using wide excision. 
A histological assay showed that the recurrent tumor was 
3.8 cm sized in diameter and had an irregular margin. On sec-
tioning, the cut surface showed fibrous bands and lobular adi-
pose tissue with focal congestion without necrosis. The nodules 
Figure 1. Initial radiologic findings. (A) Mammography showing prominent fibroglandular tissue in the subareolar area of left breast. (B) Ultrasonogra- 
phic scan showing heterogeneous hypoechoic lesion with diffuse skin thickening and fatty infiltration.
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Figure 2. Histological findings of the left breast mass by core needle bi-
opsy. Marked infiltration of plasma cells and eosinophils have been 
shown. Many atypical cells with large nuclei in the abundant collage-
nous stroma can be seen (H&E stain, ×400). UndifferentiatedPleomorphicSarcomaoftheMaleBreast 243
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were composed of plump to spindle-shaped fibroblasts, many 
lymphoplasma cells, eosinophilic infiltrate, and many keloid-
like collagen bundles. Microscopic findings were similar to the 
previous histological findings (Figure 5A), but many atypical 
cells and abnormal mitotic activity ranging from 6 to 10 mitotic 
figures per 10 high power fields (hpf) were noted and the re-
Figure 3. Initial histological appearance of the left breast mass after 
wide excision. (A, B) Microscopic findings of the specimen showing 
nodular proliferation of fibrous tissue with focal infiltrating margins. Spin-
dle fibroblasts with many lymphoplasma cells and eosinophils were ap-
parent. A few atypical cells and pleomorphic cells were noted, but ab-
normal mitosis was not identified (H&E stain; A, ×40; B, ×400). (C) Im-
munohistochemical staining for S-100 protein shows negative staining 
in tumors (×200).
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Figure 4. Radiologic findings of a recurrent mass in left breast. (A) Computed tomography (CT) image showing a low attenuating mass in the subare-
olar area of the left breast (arrow) without significant lymph node enlargement. (B) Positron emission tomography-CT image showing faint FDG uptake 
area in the left breast (arrow) without other metabolically significant FDG uptake lesions that would suggest axillary nodal or distant organ metastasis.
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sected margins were involved with the tumor (Figure 5B, C). 
Based on the rapid recurrence of the mass, increase in tumor 
size, high degree of cellularity, presence of atypical cells, many 
abnormal mitotic figures, and infiltrating growth pattern, ma-
lignancy was indicated. The immunohistochemical staining 
for CD34 showed focal positivity; however, the cells were not 
reactive for other immunomarkers including cytokeratin (CK), 
epithelial membrane antigen (EMA), SMA, murine double-
minute protein 2 (MDM2), desmin, S-100 protein, CD68 and 
anaplastic lymphoma kinase (ALK). These established histol- 
ogical features of malignant pleomorphic spindle cell tumor 
in addition to the immunohistochemical results demonstrated 
no line of differentiation and led to the diagnosis of undiffer-
entiated pleomorphic sarcoma of the breast. Due to the involve-
ment of the resected margin, the patient underwemt simple 
mastectomy.
DISCUSSION
Primary breast sarcoma is a rare type of cancer arising from 
the mesenchymal tissue of the breast and represents less than 
1% of all breast malignancies. It includes a heterogeneous 
group of disease entities. According to the World Health Or-
ganization (WHO) classification, malignant fibrous histio- 
cytoma (MFH) is a morphological pattern rather than a dis-
tinct clinicopathological entity. Many neoplasms diagnosed as 
MFH previously are actually classified as pleomorphic subtypes 
of other sarcomas [2]. Pleomorphic MFH/undifferentiated 
pleomorphic sarcoma is defined as a group of pleomorphic, 
high-grade sarcomas showing no line of differentiation. 
Undifferentiated pleomorphic sarcoma has been a diagno-
sis of exclusion following thorough sampling and critical use 
of ancillary diagnostic techniques. In the previous reports, it 
consisted of 10.5-24% of all primary breast sarcomas [4,6]. 
Most undifferentiated pleomorphic sarcomas have appeared 
in patients who are in their sixth and seventh decade of life [2]. 
Neither the symptoms nor the physical findings of undifferen-
tiated pleomorphic sarcoma of the breast present any charac-
teristic pattern that would easily suggest the diagnosis. Immu-
nohistochemistry may be useful to distinguish primary breast 
sarcomas from non-mesenchymal malignant tumors and to 
delineate the level of differentiation of primary breast sarco-
Figure 5. Histological appearance of the recurrent left breast mass,       
diagnosed as pleomorphic spindle cell sarcoma. (A) Fibrous bands and 
lobular adipose tissue with focal congestion and no necrosis (H&E stain, 
×40). (B) Microscopic findings showed spindle tumor cells with many 
lymphoplasma cells and eosinophilic infiltrates (H&E stain,  ×200). (C) 
Many atypical cells and abnormal mitoses were noted (H&E stain, 
×400 ).
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C
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mas [5]. Desmin, vimentin, smooth muscle antigen, CK, leu-
kocyte common antigen, CD34, HMB-45, SMA, EMA, and 
S-100 protein should all be analyzed in sarcoma patients.
Undifferentiated pleomorphic sarcomas often grow rapidly 
and then may be painful. Imaging methods and macroscopy 
have revealed well-circumscribed masses with heterogeneous 
composition. Further, they have been identified as pale fibrous 
and fleshy areas admixed with zones of (cystic) necrosis, hem-
orrhage, or myxoid features [7]. Microscopically, lesions ex- 
ihibits cells showing marked pleomorphism admixed with bi-
zarre giant cells, spindle cells, and variable foamy cells [8]. A 
storiform growth pattern and variable chronic inflammatory 
cells are also common [7]. 
Limited data on undifferentiated pleomophic sarcoma have 
indicated that this neoplasm has an aggressive clinical course 
and high incidence of recurrence and metastasis. Overall 5- 
year survival of patients with undifferentiated pleomophic 
sarcoma has been roughly 50% [7]. Local surgical resection is 
the choice of treatment and negative margins are particularly 
important, although the extent of the surgery has been con-
troversial. Axillary dissection has been generally thought to be 
unnecessary for undifferentiated pleomophic sarcoma of the 
breast, since these tumors rarely metastasize via the lympha- 
tics [9,10]. The role of adjuvant chemotherapy and radiation 
also has been unclear [9,10]. In our case, the patient was sub-
jected to wide local excision for recurrent mass without axil-
lary dissection and will undergo simple mastectomy due to 
involvement of the resected margin.
Differential diagnosis should include metaplastic (saroma-
toid) carcinoma, malignant phyllodes tumor, inflammatory 
myofibroblastic tumor (IMT), and myofibrosarcoma.
Metaplastic (sarcomatoid) carcinoma, also called spindle cell 
carcinoma, is a rare heterogeneous neoplasm generally char-
acterized by a mixture of adenocarcinoma with dominant ar-
eas of spindle cells, squamous and other mesenchymal differ-
entiation [11]. CK positivity of the spindle cells confirms the 
epithelial origin of this tumor. 
Malignant phyllodes tumor consists of malignant mesen-
chymal cells and a benign epithelial component [5]. The tumor 
shows overgrowth of the stroma in relation to the epithelial 
component, cellular pleomorphism with sarcomatous ele-
ments and frequent mitoses, and invasion of the surrounding 
tissues. The tumor can be differentiated from undifferentiated 
pleomorphic sarcoma by more extensive sampling for identi-
fying epithelial component. 
IMT is a neoplasm of myofibroblastic origin, often admixed 
with prominent inflammatory infiltrate consisting of lympho-
cytes, plasma cells, macrophages, eosinophils and histiocytes. 
An IMT is a low-grade neoplastic lesion showing lack of atyp-
ia, hyperchromasia, and abnormal mitotic figures [12]. Immu-
nohistochemistry of IMT shows strong SMA reactivity within 
the spindle cells frequently and occasional immunoreactivity 
for ALK, and negative or focal positivity for pankeratin.
Myofibrosarcomas are malignant tumors of myofibroblasts. 
Electron microscopy examination has been considered a gold 
standard for diagnosis of myofibrosarcoma, and ultrastruc- 
turally, the neoplastic cells have variable rough endoplasmic 
reticulum (RER) as well as peripheral filament bundles resem-
bling stress fibers, collagen secretion granules and, rarely fibro-
nectin fibrils and a fibronexus junction [13]. Most myofibro-
sarcomas are immunoreactive for SMA and expression of CK, 
EMA, CD34, desmin or S100 protein is seen sporadically. 
Although rare, benign spindle cell lesions of the breast may 
show malignant progression as in our case; however, breast 
sarcoma may be misdiagnosed as benign spindle cell lesions 
such as myofibroblastoma, nodular fasciitis and fibromatosis. 
The histological criteria for the diagnosis of benign spindle cell 
neoplasms includes well-circumscribed cells, monomorphic, 
bland-looking spindle to oval-shaped cells, minimal to mod-
erate cytological atypia, fascicular and/or haphazard growth 
pattern; absence of epithelial and myoepithelial components; 
mitotic activity of 2 or less per 10 hpf, and the absence of both 
atypical mitosis and necrosis [14].
Myofibroblastoma is a benign prototypic tumor of mam-
mary stroma [13]. Currently, it is believed that myofibroblas-
toma occurs mainly in older men and postmenopausal wom-
en. Morphologic features of classic-type myofibroblastoma are 
purely mesenchymal tumor with no epimyoepithelial compo-
nents, interspersed thick hyalinized collagen bundles, low mi-
totic count, lack of marked cytologic atypia, no atypical mito-
ses, and the absence of necrosis. Most myofibroblastomas are 
typically positive to vimentin, desmin, and CD34 and immu-
noreactivity for SMA, bcl-2, and CD99 is frequently obtained 
[13].
Nodular fasciitis is a rapidly growing lesion, which is usually 
subcutaneous and does not reach a large size. Microscopically, 
the lesion is fairly well circumscribed. It consists of plump ac-
tive fibroblasts and myofibroblasts arranged in short, loose and 
irregular bundles. Nodular fasciitis is less cellular and uniform 
than undifferentiated pleomorphic sarcoma and does not in-
filtrate into surrounding tissue. Unlike in undifferentiated 
pleomorphic sarcoma, nuclear atypia and necrosis are not 
seen [5,14].
Fibromatosis is non-encapsulated well-differentiated fibro-
blastic lesion composed of relatively uniform fibroblasts and 
collagen forming a firm, solitary, or multinodular mass with an 
infiltrative growth pattern. Immunohistochemically, fibroma-
tosis exhibits positivity for SMA and vimentin and negativity 246  YoungJuJeong,etal.
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for CK, estrogen, progesterone and androgen receptors [15].
In our case, the histological sections of the initially excised 
tumor showed nodular proliferation of fibrous tissue with       
focal infiltrating margins; and it was composed of plump to 
spindle-shaped fibroblasts, eosinophilic infiltrates, many lym-
phoplasma cells, many keloid-like collagen bundles, a few atyp-
ical cells, including multinuclear giant cells and pleomorphic 
cells. The lack of abnormal mitosis was pointed towards a be-
nign spindle cell lesion, and negative immunoreactivity for 
desmin, SMA, and S-100 protein was useful to exclude lesions 
with myofibroblastic components or differentiation such as 
myofibroblastoma, nodular fasciitis, or fibromatosis. However, 
the histological sections of the recurrent tumor exhibited dif-
ferent features compared to the initial histological findings; it 
revealed increased multinucleated giant and atypical tumor 
cells and abnormal mitosis, and it was suggestive of malig- 
nancy. This case did not arise from the epithelial tissue but 
from the mesenchymal tissue of the breast, being consistent 
with the negative immunoreactivity for CK, EMA, SMA, des-
min and S-100 protein. Histologic findings of many atypical 
cells and abnormal mitotic activity, a negative immunoreac-
tivity for SMA and ALK helped to exclude IMT from the dif-
ferential diagnostic consideration. This case was distinguished 
from myofibroblastoma by negative immunoreactivity for 
SMA, CK, EMA, CD34, desmin and S100 protein. Although 
histological features of the recurrent mass were suggestive of a 
malignant pleomorphic spindle cell tumor, the immunohisto-
chemical results failed to disclose the line of differentiate of 
the lesion. Hence, the final diagnosis of the tumor was undif-
ferentiated pleomorphic sarcoma. 
In conclusion, most breast cancers originate from the epithe-
lium, and mesenchymal breast tumors are rarely seen, especial-
ly in men. Also, undifferentiated pleomorphic sarcoma, one 
subtype of primary breast sarcoma has been uncommon and 
these lesions represent special diagnostic difficulties. Herein, 
we reported a case of the undifferentiated pleomorphic sar- 
coma occurring in the male breast. Initially, it was difficult to 
classify the lesion as undifferentiated pleomorphic sarcoma; fi-
nally, based on histological findings and the immunohistochem-
ical results of the tumor, we diagnosed the recurrent mass as 
undifferentiated pleomorphic sarcoma. In case of undifferenti-
ated pleomorphic sarcoma of the breast, surgical excision of the 
tumor with adequate margins seems to be the most significant 
prognostic factor; therefore, it will be necessary to treat this pa-
tient with repeated excision or simple mastectomy to prevent 
local recurrence and to improve his chances of survival.
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